Skip to main content
Signal8

Jaguar Health, Inc. (JAGX) Form 424B3 — Nov 9, 2026

$JAGXForm 424B3Filed Nov 9, 2026, 7:46 AM ET0001193125-26-452676Original filing

Jaguar Health filed a 424B3 base prospectus registering up to $75,000,000 of common stock, preferred stock, warrants, subscription rights, and units for sale from time to time off its Form S-3 shelf. No securities are being sold in this filing itself; each future takedown will require its own prospectus supplement. The filing comes with the stock at $0.8841 (Nov 2, 2026) and only ~13.3 million shares outstanding after the Series R preferred converted 5-for-1 on November 2, 2026. A full $75M shelf takedown against that share count would represent extreme potential dilution.

Key figures

Gross Proceeds
75000000
Offering Price
0.8841
Shares Outstanding
13345986
Share price as of
2026-11-02
Future pak upfront capital
16000000
Future pak milestones potential
20000000
Shares of series r converted 5 to 1
2188712
Streeterville 2025 note original principal
10810000

AI analysis

Red flags5 · Pro

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.

    Jaguar Health, Inc. (JAGX) Form 424B3 — Nov 9, 2026: AI Analysis | Signal8